SK Bioscience Co Ltd
KRX:302440

Watchlist Manager
SK Bioscience Co Ltd Logo
SK Bioscience Co Ltd
KRX:302440
Watchlist
Price: 47 850 KRW -1.34% Market Closed
Market Cap: 3.7T KRW
Have any thoughts about
SK Bioscience Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one SK Bioscience Co Ltd stock under the Base Case scenario is 35 489.69 KRW. Compared to the current market price of 47 850 KRW, SK Bioscience Co Ltd is Overvalued by 26%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
35 489.69 KRW
Overvaluation 26%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
SK Bioscience Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for SK Bioscience Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about SK Bioscience Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about SK Bioscience Co Ltd

Provide an overview of the primary business activities
of SK Bioscience Co Ltd.

What unique competitive advantages
does SK Bioscience Co Ltd hold over its rivals?

What risks and challenges
does SK Bioscience Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for SK Bioscience Co Ltd.

Provide P/S
for SK Bioscience Co Ltd.

Provide P/E
for SK Bioscience Co Ltd.

Provide P/OCF
for SK Bioscience Co Ltd.

Provide P/FCFE
for SK Bioscience Co Ltd.

Provide P/B
for SK Bioscience Co Ltd.

Provide EV/S
for SK Bioscience Co Ltd.

Provide EV/GP
for SK Bioscience Co Ltd.

Provide EV/EBITDA
for SK Bioscience Co Ltd.

Provide EV/EBIT
for SK Bioscience Co Ltd.

Provide EV/OCF
for SK Bioscience Co Ltd.

Provide EV/FCFF
for SK Bioscience Co Ltd.

Provide EV/IC
for SK Bioscience Co Ltd.

Show me price targets
for SK Bioscience Co Ltd made by professional analysts.

What are the Revenue projections
for SK Bioscience Co Ltd?

How accurate were the past Revenue estimates
for SK Bioscience Co Ltd?

What are the Net Income projections
for SK Bioscience Co Ltd?

How accurate were the past Net Income estimates
for SK Bioscience Co Ltd?

What are the EPS projections
for SK Bioscience Co Ltd?

How accurate were the past EPS estimates
for SK Bioscience Co Ltd?

What are the EBIT projections
for SK Bioscience Co Ltd?

How accurate were the past EBIT estimates
for SK Bioscience Co Ltd?

Compare the revenue forecasts
for SK Bioscience Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of SK Bioscience Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of SK Bioscience Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of SK Bioscience Co Ltd compared to its peers.

Compare the P/E ratios
of SK Bioscience Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing SK Bioscience Co Ltd with its peers.

Analyze the financial leverage
of SK Bioscience Co Ltd compared to its main competitors.

Show all profitability ratios
for SK Bioscience Co Ltd.

Provide ROE
for SK Bioscience Co Ltd.

Provide ROA
for SK Bioscience Co Ltd.

Provide ROIC
for SK Bioscience Co Ltd.

Provide ROCE
for SK Bioscience Co Ltd.

Provide Gross Margin
for SK Bioscience Co Ltd.

Provide Operating Margin
for SK Bioscience Co Ltd.

Provide Net Margin
for SK Bioscience Co Ltd.

Provide FCF Margin
for SK Bioscience Co Ltd.

Show all solvency ratios
for SK Bioscience Co Ltd.

Provide D/E Ratio
for SK Bioscience Co Ltd.

Provide D/A Ratio
for SK Bioscience Co Ltd.

Provide Interest Coverage Ratio
for SK Bioscience Co Ltd.

Provide Altman Z-Score Ratio
for SK Bioscience Co Ltd.

Provide Quick Ratio
for SK Bioscience Co Ltd.

Provide Current Ratio
for SK Bioscience Co Ltd.

Provide Cash Ratio
for SK Bioscience Co Ltd.

What is the historical Revenue growth
over the last 5 years for SK Bioscience Co Ltd?

What is the historical Net Income growth
over the last 5 years for SK Bioscience Co Ltd?

What is the current Free Cash Flow
of SK Bioscience Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for SK Bioscience Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
SK Bioscience Co Ltd

Current Assets 1.5T
Cash & Short-Term Investments 1.3T
Receivables 51.1B
Other Current Assets 118B
Non-Current Assets 544.7B
Long-Term Investments 22.4B
PP&E 415.7B
Intangibles 28.7B
Other Non-Current Assets 77.9B
Current Liabilities 128.5B
Accounts Payable 13B
Accrued Liabilities 10.9B
Other Current Liabilities 104.7B
Non-Current Liabilities 199.7B
Long-Term Debt 199B
Other Non-Current Liabilities 664.3m
Efficiency

Earnings Waterfall
SK Bioscience Co Ltd

Revenue
201.3B KRW
Cost of Revenue
-146.5B KRW
Gross Profit
54.8B KRW
Operating Expenses
-152B KRW
Operating Income
-97.2B KRW
Other Expenses
54B KRW
Net Income
-43.3B KRW

Free Cash Flow Analysis
SK Bioscience Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

SK Bioscience Co Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Negative Net Income
Positive Revenue Growth Forecast
42/100
Profitability
Score

SK Bioscience Co Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

SK Bioscience Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

SK Bioscience Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
SK Bioscience Co Ltd

Wall Street analysts forecast SK Bioscience Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SK Bioscience Co Ltd is 51 170 KRW with a low forecast of 40 400 KRW and a high forecast of 63 000 KRW.

Lowest
Price Target
40 400 KRW
16% Downside
Average
Price Target
51 170 KRW
7% Upside
Highest
Price Target
63 000 KRW
32% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SK Bioscience Co Ltd?

Click here to dive deeper.

Dividends

SK Bioscience Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for SK Bioscience Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

SK Bioscience Co Ltd Logo
SK Bioscience Co Ltd

Country

Korea

Industry

Biotechnology

Market Cap

3.7T KRW

Dividend Yield

0%

Description

SK bioscience Co., Ltd. engages in the development and distribution of bio and vaccine products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-03-18. The firm's main products include vaccines such as SKYCellflu and Rotatech. The firm also sells infusion solutions. In addition, the Company engages in technology export business. The firm sells its products in domestic and overseas markets.

Contact

GYEONGGI-DO
Seongnam
310, Pangyo-ro, Bundang-gu
+82220082200
www.skbioscience.co.kr

IPO

2021-03-18

Employees

1 067

Officers

CEO, President & Director
Mr. Jae-Yong Ahn
Head of Global Clinical Development & Regulatory Affairs
Dr. Sally Choe

See Also

Discover More
What is the Intrinsic Value of one SK Bioscience Co Ltd stock?

The intrinsic value of one SK Bioscience Co Ltd stock under the Base Case scenario is 35 489.69 KRW.

Is SK Bioscience Co Ltd stock undervalued or overvalued?

Compared to the current market price of 47 850 KRW, SK Bioscience Co Ltd is Overvalued by 26%.

Back to Top